Omicron Hospitalizations: What We Know So Far

The Omicron variant of COVID-19 has led to hospitalizations, contrary to some early claims. While there is no comprehensive data on Omicron hospitalizations, early data from South Africa, the United Kingdom, and Denmark suggest a reduced risk of hospitalization compared to previous variants. However, increased transmission of Omicron is expected to lead to more hospitalizations. In the United States, a study by the UK Health Security Agency included 815 people with Omicron who were admitted to hospitals or transferred from emergency departments. The impact of Omicron varies across communities, with some communities experiencing higher infection and lower vaccination rates, resulting in more severe outcomes. Overall, while Omicron may cause a reduced risk of hospitalization, the increased transmission can still lead to a significant number of hospitalizations, especially in vulnerable communities.

There have been hospitalizations from Omicron

There have indeed been hospitalizations from the Omicron variant of COVID-19. While early data from South Africa, the United Kingdom, and Denmark suggested a reduced risk of hospitalization for Omicron compared to the Delta variant, the increased transmission of Omicron is expected to lead to more hospitalizations. The World Health Organization (WHO) has emphasized that it is still unclear to what extent the reduced risk of hospitalization is due to immunity from previous infections or vaccinations, or whether Omicron is inherently less virulent.

In the United States, there have been hospitalizations attributed to Omicron. For instance, a study published on January 1, 2022, included 815 people with Omicron who were admitted to hospitals or transferred from emergency departments. Furthermore, hospitals such as Signature Brockton Hospital and Lawrence General Hospital, which serve communities of color and Latino communities respectively, have experienced high percentages of patients requiring intensive care during the Omicron surge. These communities have historically faced health disparities with higher infection and lower vaccination rates.

The Omicron variant has also resulted in hospitalizations in other countries. For instance, the NB.1.8.1 subvariant of Omicron has been associated with rising cases and hospitalizations globally, particularly in countries where it is more prominent. While it may not cause more severe illness, NB.1.8.1 has been shown to be more transmissible, allowing it to spread more easily from person to person. This increased transmissibility can contribute to a higher number of hospitalizations overall.

It is important to note that while there may be a reduced need for oxygen support and ventilators with the Omicron variant, patients who are hospitalized still require prolonged care. Additionally, the intensity of illness in intensive care units remains unchanged, with unvaccinated individuals comprising the majority of these cases. Therefore, while the overall hospitalization rates and severity of Omicron may be lower compared to previous COVID-19 waves, it is crucial to remain vigilant and continue following public health guidelines.

Omicron patients are less likely to need oxygen support

While there is no comprehensive data on Omicron hospitalizations, early data from South Africa, the United Kingdom, and Denmark suggests a reduced risk of hospitalization for Omicron compared to the Delta variant. However, increased transmission due to Omicron is expected to lead to more hospitalizations.

Dr. Angelique Coetzee, who first detected the Omicron variant in South Africa, noted that patients infected with the variant had not required oxygen support. She described the symptoms as mild, including a sore throat and a slight cough. Dr. Coetzee advised that even if one is feeling mildly unwell, they should get tested.

Similarly, Dr. Suresh Kumar from Lok Nayak Jai Prakash Narayan Hospital in Delhi, India, reported that none of the Omicron patients at the hospital needed oxygen support, steroids, Remdesivir, or a ventilator. The doctor observed that 90% of the patients were asymptomatic, while the remaining exhibited mild symptoms such as a sore throat, low-grade fever, and body aches.

These early indications suggest that Omicron patients are less likely to need oxygen support and experience less severe symptoms compared to previous strains of the coronavirus. However, it is important to note that the situation may evolve as more data becomes available, and precautions should still be taken to prevent the spread of the virus.

ICU patients with Omicron are just as sick as those with other variants

While there is no comprehensive data on Omicron-related hospitalizations, it is incorrect to claim that there have been zero hospitalizations from the variant. Early data from South Africa, the United Kingdom, and Denmark suggest a reduced risk of hospitalization for Omicron compared to previous variants, but increased transmission rates may lead to more hospitalizations. The World Health Organization (WHO) has emphasized that it is still unclear whether the reduced risk of hospitalization is due to immunity from previous infections or vaccinations, or if Omicron is inherently less virulent.

Despite initial reports, there have indeed been hospitalizations due to the Omicron variant. A study published on January 1, 2022, included data on 862 Omicron patients who were symptomatic. Additionally, the UK Health Security Agency's study comprised 815 Omicron patients who were admitted to hospitals or transferred from emergency departments. These studies refute the claim made in a campaign advertisement by Sen. Rand Paul, stating that no one had been hospitalized due to the Omicron variant.

While the Omicron variant may have exhibited a reduced risk of hospitalization compared to previous variants, it is important to understand that people can still become severely ill from this or any other variant of COVID-19. Hospitalization rates can be influenced by various factors, including the age and health of the infected individuals, as well as their vaccination status. According to the CDC, certain groups are more likely to develop severe illness, including people over the age of 65, young infants, and those who are immunocompromised or have underlying medical conditions.

The emergence of new variants, such as NB.1.8.1, a descendant of the Omicron variant, further underscores the importance of remaining vigilant. NB.1.8.1 has been detected in multiple countries, including the United States, and is highly contagious. While the severity of NB.1.8.1 compared to other variants is still under investigation, it is crucial to recognize that COVID-19 can cause severe illness, regardless of the variant. The CDC recommends staying up to date with COVID-19 vaccines, as they provide protection against currently circulating strains, including variants of Omicron.

In conclusion, while early data suggested a reduced risk of hospitalization for Omicron compared to other variants, it is inaccurate to state that there were zero hospitalizations from this variant. The risk of hospitalization is influenced by various factors, and new variants continue to emerge. Staying vigilant, monitoring symptoms, and staying up to date with vaccinations are crucial to protecting against severe illness, hospitalization, and death from COVID-19 and its variants.

Omicron hospitalizations are more prevalent in communities with lower vaccination rates

While there is a lack of comprehensive data on Omicron hospitalizations, early research from South Africa, the United Kingdom, and Denmark suggests that the risk of hospitalization is lower for Omicron compared to previous variants. However, the increased transmissibility of Omicron may result in more hospitalizations overall.

It is important to note that the severity of Omicron infections can vary depending on the vaccination status of the population. Unvaccinated individuals infected with the Omicron variant face an increased risk of hospitalization. On the other hand, vaccinated individuals, especially those who have received a booster dose, are less likely to require hospitalization if infected with Omicron. This indicates that vaccination plays a crucial role in preventing severe illness and reducing the burden on healthcare systems.

During the Omicron wave, regions with lower vaccination rates might have experienced higher hospitalization rates. This could be due to a combination of factors, including a larger proportion of unvaccinated individuals and a higher likelihood of breakthrough infections among those with incomplete or waning immunity. Additionally, socioeconomic factors and access to healthcare services may also contribute to the variability in hospitalization rates across different communities.

To reduce the prevalence of Omicron hospitalizations in communities with lower vaccination rates, public health efforts should focus on increasing vaccine accessibility and addressing vaccine hesitancy. Ensuring equitable distribution of vaccines and providing accurate information about their safety and efficacy can help improve vaccination rates in underserved areas. Additionally, continued adherence to preventive measures, such as masking, social distancing, and testing, remains crucial in mitigating the impact of Omicron and reducing the strain on healthcare resources.

While Omicron may cause less severe illness on average, it is important to remember that it can still lead to severe disease and hospitalization, especially in vulnerable populations, including the elderly, immunocompromised individuals, and those with underlying health conditions. Therefore, a multifaceted approach that combines vaccination, preventive measures, and targeted interventions for at-risk groups is essential to minimize the impact of Omicron and protect public health.

Omicron patients are less likely to lose their sense of taste or smell

There have been hospitalizations due to the Omicron variant of COVID-19. While there is no comprehensive data on Omicron hospitalizations, early data from South Africa, the United Kingdom, and Denmark suggest a reduced risk of hospitalization for Omicron compared to the Delta variant. The World Health Organization has stated that increased transmission due to Omicron is expected to lead to more hospitalizations.

Regarding the loss of taste and smell, this symptom was more prevalent with earlier variants of COVID-19, and fewer people are reporting these issues now that Omicron is the dominant strain. Research suggests that the Omicron variant is less likely to affect chemosensory function and that it does so less severely when compared to earlier variants. A study by researchers in Italy and the UK found that 90% of mildly symptomatic COVID-19 patients who experienced a loss of taste or smell fully regained these senses within two years.

The loss of taste and smell was one of the most distinctive symptoms of COVID-19 at the start of the pandemic. However, with time and the emergence of new variants, this symptom has become less dominant. Research has shown that experiencing smell or taste loss significantly reduces quality of life, particularly mental health. For example, one study of over 300 COVID patients with taste or smell loss saw 43% report feelings of depression.

While the Omicron variant is less likely to cause a loss of taste and smell, it is important to note that this symptom can still occur, albeit less frequently and severely. A study found that around 12% of people with European ancestry infected with the Omicron variant experienced a loss of taste and smell. Overall, the available data suggests that Omicron patients are less likely to lose their sense of taste or smell compared to patients infected with earlier variants of COVID-19.

Frequently asked questions